相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
Shaoquan Zheng et al.
ONCOIMMUNOLOGY (2022)
Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
Xia Qiu et al.
FRONTIERS IN ONCOLOGY (2022)
The role of Th17 cells in the pathogenesis and treatment of breast cancer
Vahid Karpisheh et al.
CANCER CELL INTERNATIONAL (2022)
Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer
Swarnima Singh et al.
CANCER RESEARCH (2022)
Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF
Yan-Ting Zhou et al.
CANCER SCIENCE (2022)
Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination
Riccardo Pecori et al.
NATURE REVIEWS GENETICS (2022)
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
J. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
Mercedes Tkach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
Laura Carpen et al.
CELL DEATH DISCOVERY (2022)
Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling
Xiangzhou Chen et al.
CELL COMMUNICATION AND SIGNALING (2022)
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
Ernestina Marianna De Francesco et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2022)
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Macrophage diversity in cancer revisited in the era of single-cell omics
Ruo-Yu Ma et al.
TRENDS IN IMMUNOLOGY (2022)
Simulations of tumor growth and response to immunotherapy by coupling a spatial agentbased model with a whole-patient quantitative systems pharmacology model
Alvaro Ruiz-Martinez et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang et al.
ISCIENCE (2022)
LYMPHATIC VESSELS IN CANCER
Lothar C. Dieterich et al.
PHYSIOLOGICAL REVIEWS (2022)
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Yuanyuan Zhang et al.
CANCER CELL (2021)
Regulatory B cells in cancer
Daniel Michaud et al.
IMMUNOLOGICAL REVIEWS (2021)
Cell type-selective secretome profiling in vivo
Wei Wei et al.
NATURE CHEMICAL BIOLOGY (2021)
Pan-cancer single cell landscape of tumor-infiltrating T cells
Liangtao Zheng et al.
SCIENCE (2021)
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
Hajime Kuroda et al.
BREAST CANCER (2021)
A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast
Bhupinder Pal et al.
EMBO JOURNAL (2021)
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis
Kun Xu et al.
ONCOGENESIS (2021)
S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells
Maria Francesca Santolla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi et al.
NPJ BREAST CANCER (2021)
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Ayse Bassez et al.
NATURE MEDICINE (2021)
Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Zowi R. Huinen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity
Eun-Sook Kim et al.
ONCOGENE (2021)
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
Elisa Agostinetto et al.
CURRENT ONCOLOGY REPORTS (2021)
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling
Qingtao Hu et al.
NATURE COMMUNICATIONS (2021)
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
Robert J. Harris et al.
CANCER RESEARCH (2021)
Fibroblasts: Origins, definitions, and functions in health and disease
Maksim Plikus et al.
CELL (2021)
A single-cell and spatially resolved atlas of human breast cancers
Sunny Z. Wu et al.
NATURE GENETICS (2021)
Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics
Sophia K. Longo et al.
NATURE REVIEWS GENETICS (2021)
NK and NKT cells have distinct properties and functions in cancer
Xia Liu et al.
ONCOGENE (2021)
Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer
Arushi Jaiswal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
Rokana Taftaf et al.
NATURE COMMUNICATIONS (2021)
Neoantigens elicit T cell responses in breast cancer
Takafumi Morisaki et al.
SCIENTIFIC REPORTS (2021)
Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5
Daniel C. Rabe et al.
CANCERS (2021)
Tumor-on-a-chip: from bioinspired design to biomedical application
Xingxing Liu et al.
MICROSYSTEMS & NANOENGINEERING (2021)
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
Yves Boucher et al.
NPJ PRECISION ONCOLOGY (2021)
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Kai Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
Li Cong et al.
BREAST CANCER RESEARCH (2021)
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
Sakar Wahby et al.
CLINICAL CANCER RESEARCH (2021)
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K. Mehta et al.
NATURE CANCER (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R. Barroso-Sousa et al.
ANNALS OF ONCOLOGY (2020)
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
Jermaine Goveia et al.
CANCER CELL (2020)
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
Caroline Bergenfelz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production
Jeong-Hoon Jang et al.
CANCER RESEARCH (2020)
The significance of exosomes in the development and treatment of hepatocellular carcinoma
Xin Li et al.
MOLECULAR CANCER (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy
Marie K. Malone et al.
CANCER BIOLOGY & THERAPY (2020)
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Yiwen Lu et al.
CELL (2020)
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets
Rosamaria Lappano et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity
Jing Ni et al.
IMMUNITY (2020)
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Rachael M. Zemek et al.
FRONTIERS IN IMMUNOLOGY (2020)
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Aviad Ben-Shmuel et al.
FRONTIERS IN IMMUNOLOGY (2020)
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
Teresa Gagliano et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Ge Qin et al.
NATURE COMMUNICATIONS (2020)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner et al.
FRONTIERS IN IMMUNOLOGY (2020)
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
Aimy Sebastian et al.
CANCERS (2020)
Stromal cell diversity associated with immune evasion in human triple-negative breast cancer
Sunny Z. Wu et al.
EMBO JOURNAL (2020)
Role of Tumor-Associated Myeloid Cells in Breast Cancer
Yoon Jin Cha et al.
CELLS (2020)
Cancer cells educate natural killer cells to a metastasis-promoting cell state
Isaac S. Chan et al.
JOURNAL OF CELL BIOLOGY (2020)
Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells
Valenti Gomez et al.
SCIENCE SIGNALING (2020)
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
Haoyang Mi et al.
FRONTIERS IN PHYSIOLOGY (2020)
Targeting IL-3R alpha on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
Tatiana Lopatina et al.
ONCOGENESIS (2020)
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K. Gupta et al.
CANCERS (2020)
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives
Laurenz Nagl et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide
Adam C. Mirando et al.
ONCOIMMUNOLOGY (2020)
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Miguel Quintela-Fandino et al.
BREAST CANCER RESEARCH (2020)
B cells, plasma cells and antibody repertoires in the tumour microenvironment
George Sharonov et al.
NATURE REVIEWS IMMUNOLOGY (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
John D. Martin et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
Roles of NKT cells in cancer immunotherapy
Eun-Ah Bae et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
The neoepitope landscape of breast cancer: implications for immunotherapy
Pooja Narang et al.
BMC CANCER (2019)
Monocyte heterogeneity and functions in cancer
Claire E. Olingy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Yueh-Shan Weng et al.
MOLECULAR CANCER (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Johanna Wagner et al.
CELL (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
Fei Chen et al.
NATURE CELL BIOLOGY (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Marcelo G. Kazanietz et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
Ik Sun Kim et al.
NATURE CELL BIOLOGY (2019)
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
Lea Monteran et al.
FRONTIERS IN IMMUNOLOGY (2019)
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Daniel P. Hollern et al.
CELL (2019)
Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Miseon Lee et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi et al.
CELL (2018)
Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Hope S. Rugo et al.
CLINICAL CANCER RESEARCH (2018)
Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling
Wenwen Zhang et al.
FASEB JOURNAL (2018)
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Paula Michea et al.
NATURE IMMUNOLOGY (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Yaming Li et al.
CELL DEATH & DISEASE (2018)
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Aurelie S. Cazet et al.
NATURE COMMUNICATIONS (2018)
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
David M. Goldenberg et al.
Oncotarget (2018)
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Jhajaira M. Araujo et al.
SCIENTIFIC REPORTS (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
Michael Bartoschek et al.
NATURE COMMUNICATIONS (2018)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Y. Dirix et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo
Jing Wu et al.
ONCOTARGET (2017)
The Broad Spectrum of Human Natural Killer Cell Diversity
Aharon G. Freud et al.
IMMUNITY (2017)
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Xuetian Yue et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Brain-derived neurotrophic factor (BDNF) - TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer
Yi-Fang Tsai et al.
PLOS ONE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Woosung Chung et al.
NATURE COMMUNICATIONS (2017)
Breast cancer cell-derived exosomes and macrophage polarization are associated with lymph node metastasis
Yin Ji Piao et al.
Oncotarget (2017)
Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells
Zhengda Sun et al.
Oncotarget (2017)
Circulatory and maturation kinetics of human monocyte subsets in vivo
Tamar Tak et al.
BLOOD (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Katharina Maisel et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers
Martina Di Modica et al.
CANCER LETTERS (2017)
A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6
Wenjing Tian et al.
CANCER SCIENCE (2016)
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
Roni Allaoui et al.
NATURE COMMUNICATIONS (2016)
The hedgehog pathway in triple-negative breast cancer
Joyce G. Habib et al.
CANCER MEDICINE (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment
Esak Lee et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Patrolling monocytes control tumor metastasis to the lung
Richard N. Hanna et al.
SCIENCE (2015)
Breast cancer metastasis and the lymphatic system
Munazzah Rahman et al.
ONCOLOGY LETTERS (2015)
Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Nuket Eliyatkin et al.
JOURNAL OF BREAST HEALTH (2015)
Immune cell quantitation in normal breast tissue lobules with and without lobulitis
Amy C. Degnim et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
Svasti Haricharan et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming
Marc Dalod et al.
EMBO JOURNAL (2014)
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
Shane Crotty
IMMUNITY (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
Zhong-Yu Yuan et al.
ONCOTARGETS AND THERAPY (2014)
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Esak Lee et al.
NATURE COMMUNICATIONS (2014)
Lymphatic endothelial cells support tumor growth in breast cancer
Esak Lee et al.
SCIENTIFIC REPORTS (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Human memory T cells: generation, compartmentalization and homeostasis
Donna L. Farber et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
Isabelle Le Mercier et al.
CANCER RESEARCH (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
Vanja Sisirak et al.
CANCER RESEARCH (2012)
Normalization of tumor vasculature by R-Ras
Junko Sawada et al.
CELL CYCLE (2012)
Biglycan: A Multivalent Proteoglycan Providing Structure and Signals
Madalina V. Nastase et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells
Rodrigo Nalio Ramos et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Xi Chen et al.
CANCER INFORMATICS (2012)
Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer
Sandra A. O'Toole et al.
CANCER RESEARCH (2011)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Stewart Leung et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway
Pai-Sheng Chen et al.
JOURNAL OF CELL SCIENCE (2007)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)